AB-LIFE probiotic blend,
does it really help with Improved LDL and total cholesterol?
research showsThe CECT 7527, 7528, and 7529 blend lowered LDL and total cholesterol in an initial 60-person RCT and a later 86-person RCT. The large initial effect fell to about 3% in the later study, endpoints were lipid surrogates rather than clinical events, and findings belong only to the proprietary strain blend, supporting C with 57 points.
ads claimMarketing can describe a 'cholesterol probiotic' as though every L. plantarum strain or probiotic shares the effect. The evidence belongs to the 1:1:1 blend of CECT 7527, 7528, and 7529 and does not establish cardiovascular-event prevention or medication replacement.
Useful facts when choosing a product
- The Korean individually recognized ingredient number is 2022-14, with an intake of AB-LIFE at 1.2×10^9 CFU/day.
- Both pivotal RCTs used a 1:1:1 mixture of CECT 7527, CECT 7528, and CECT 7529.
- Korean products such as Superbiotics Cholesterol are distributed, but CFU count, storage, viable count near expiry, and added ingredients should be checked.
- The Korean regulator advises caution for disease or medication use, allergic conditions or short-bowel syndrome, infants and children, and pregnancy or lactation.
What the research actually shows
The 60-person, 12-week Fuentes 2013 RCT reported a 13.6% total-cholesterol reduction with AB-LIFE at 1.2×10^9 CFU/day and lower LDL in the high-baseline subgroup. AB-BIOTICS employees designed and analyzed the study, which received product-development funding. The 86-person German Müller 2025 RCT used the same strains and dose and found LDL changes of -6.6 mg/dL versus +2.3 mg/dL with placebo and a -10.4 mg/dL total-cholesterol change, but the effect was about 3% and responses varied widely.
Why this is classified as C (57)
Two trials of the same proprietary blend are positive and one is independently funded, but the later effect is small and differs greatly from the initial estimate, supporting C with 57 points for surrogate evidence.
Counterpoint. An adjunctive LDL and total-cholesterol signal remains for the three-strain combination at 1.2×10^9 CFU/day. This does not extend to the species as a whole or prevention of cardiovascular events.
Rejudgment record. New verdict — Positive lipid surrogates in 60-person and 86-person RCTs of the same three-strain blend, but early industry linkage, markedly different effect sizes, and proprietary attribution
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Fuentes MC et al. 2013 | Randomized double-blind placebo-controlled trial | 60 | Spanish product-development grants; conflicts involving AB-BIOTICS employees | Total cholesterol, LDL-C, and oxidized LDL-C | Total cholesterol fell 13.6%; LDL-C fell 17.6% in the high-baseline subgroup. | Key |
| Müller M et al. 2025 | Randomized double-blind placebo-controlled trial | 86 | German Research Foundation and Projekt DEAL | LDL-C, total cholesterol, triglycerides, and HDL-C | LDL-C fell about 3.2% and total cholesterol about 3.3%; triglycerides, HDL-C, and the LDL/HDL ratio did not differ between groups. | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-17).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-17 · Corrections: none
Cite this verdict
[Chamgap] AB-LIFE probiotic blend x improved LDL and total cholesterol — Evidence Grade C·57. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/ab-life-probiotic-blend-ldl-total-cholesterol/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.